Caloric restriction in humans reveals immunometabolic regulators of health span

Olga Spadaro(Yale University), Yun‐Hee Youm(Yale University), Irina Shchukina(Washington University in St. Louis), Seungjin Ryu(Yale University), Sviatoslav Sidorov(Yale University), Anthony Ravussin(Yale University), Kim Nguyen(Yale University), Ekaterina Aladyeva(Washington University in St. Louis), Alexander V. Predeus(Washington University in St. Louis), Steven R. Smith(AdventHealth Orlando), Éric Ravussin(Pennington Biomedical Research Center), Craig J. Galbán(Michigan Medicine), Maxim N. Artyomov(Washington University in St. Louis), Vishwa Deep Dixit(Yale University)
Science
February 10, 2022
Cited by 297Open Access
Full Text

Abstract

The extension of life span driven by 40% caloric restriction (CR) in rodents causes trade-offs in growth, reproduction, and immune defense that make it difficult to identify therapeutically relevant CR-mimetic targets. We report that about 14% CR for 2 years in healthy humans improved thymopoiesis and was correlated with mobilization of intrathymic ectopic lipid. CR-induced transcriptional reprogramming in adipose tissue implicated pathways regulating mitochondrial bioenergetics, anti-inflammatory responses, and longevity. Expression of the gene Pla2g7 encoding platelet activating factor acetyl hydrolase (PLA2G7) is inhibited in humans undergoing CR. Deletion of Pla2g7 in mice showed decreased thymic lipoatrophy, protection against age-related inflammation, lowered NLRP3 inflammasome activation, and improved metabolic health. Therefore, the reduction of PLA2G7 may mediate the immunometabolic effects of CR and could potentially be harnessed to lower inflammation and extend the health span.


Related Papers

No related papers found

Powered by citation graph analysis